Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Santa Monica, CA
SEC filing record 1 source field available
Fiscal year end
31 December
OPIANT PHARMACEUTICALS, INC. has filed 578 SEC EDGAR filings since 11 Jan 2007

SEC filing history

Showing 276-300 of 545 matching filings.

Per page
25
Current page
12
S-8 File 333-230450

S-8

Filing date
22 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
21 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
06 Mar 2019
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2019
Reporting date
01 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-38193

CT ORDER filing

Filing date
27 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
21 Feb 2019
Reporting date
21 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90404

SC 13G/A filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Feb 2019
Reporting date
01 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2019
Reporting date
03 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jan 2019
Reporting date
02 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
04 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
28 Dec 2018
Reporting date
28 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-38193

CT ORDER filing

Filing date
06 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2018
Reporting date
03 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38193

8-K/A

Filing date
04 Dec 2018
Reporting date
20 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-220976

424B3

Filing date
02 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38193

8-K

Filing date
02 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .